Influence of groin incision, duration of ischemia, and prostaglandin E1 on ischemia-reperfusion injury of the lower limb. 2006

Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
Department of Anesthesiology, University Hospital of Düsseldorf, Düsseldorf, Germany. fraessd@uni-duesseldorf.de

OBJECTIVE The influences of groin incision, duration of ischemia, and the effects of prostaglandin E1 (PGE1) on ischemia-reperfusion (I/R) injury of the hind limb in rabbits were evaluated. METHODS A prospective study. METHODS Laboratory. METHODS In 64 rabbits, bilateral hind limb ischemia was induced by occlusion of the abdominal aorta. Volume changes, neuromuscular function of the hind limb, and creatine kinase (CK) release were measured as variables of tissue injury. METHODS Eight rabbits served as untreated controls (CON). In 2 groups (each n = 14), 3 hours of ischemia were followed by 3 hours of reperfusion (I/R). In 2 different groups (each n = 14), 45 minutes of ischemia were followed by 2 hours of reperfusion. To determine effects of PGE1, 1 I/R group of each ischemia duration was treated intravenously with 80 ng/kg/min of PGE1 starting 30 minutes after the onset of ischemia (I/R-PGE1). To determine effects of groin incision on edema formation, volume changes were determined in the "operated" right (CON-R, 3h-R, 3h-PGE1-R and 45 min-R, 45 min-PGE1-R) or in the "nonoperated" left hind limb (CON-L, 3h-L, 3h-PGE1-L and 45 min-L, 45 min-PGE1-L), representing a subgroup analysis. RESULTS Volume changes after I/R occurred only in operated legs after ischemia (3h-R: 2.3 +/- 0.3 mL, p < 0.0001 v CON-R and 3h-L; 45 min-R: 0.8 +/- 0.2 mL, p < 0.01 v 45 min-L). PGE1 reduced edema formation in the operated legs (3h-PGE1-R: 1.0 +/- 0.4 mL, p < 0.0001 v 3h-R; 45 min-PGE1-R: 0.5 +/- 0.3 mL, p = 1.0 v 45 min-R). Groin incision without I/R had no effect on edema formation (CON-R: -0.13 +/- 0.17 mL of baseline). The increase of CK release from 616 +/- 584 U/L in controls to 5,921 +/- 2,156 U/L after 3 hours of ischemia (p < 0.001) was attenuated by treatment with PGE1 (3,732 +/- 2,653, p < 0.05 v I/R). Forty-five minutes of ischemia did not lead to cellular damage as measured by CK release (I/R: 606 +/- 364 U/L). Recovery of neuromuscular function was not affected by PGE1. CONCLUSIONS Development of edema during I/R depends on groin incision of the hind limb and on the duration of ischemia. The I/R injury is attenuated by PGE1 treatment, in terms of reduced edema formation and CK release, but not in terms of neuromuscular function.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006119 Groin The external junctural region between the lower part of the abdomen and the thigh. Groins

Related Publications

Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
February 1995, Zhonghua nei ke za zhi,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
May 1994, Pancreas,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
September 2001, Annals of plastic surgery,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
July 2000, Critical care medicine,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
January 2006, Surgery today,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
January 2015, International journal of clinical and experimental medicine,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
September 2016, Toxicology and industrial health,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
January 2007, Nephron. Physiology,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
January 1998, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
Jan Frässdorf, and Bernd Luther, and Jost Müllenheim, and Florian Otto, and Benedikt Preckel, and Wolfgang Schlack, and Volker Thämer
January 1995, Surgery today,
Copied contents to your clipboard!